Cargando…

Use of Statins in Kidney Transplant Recipients in Norway

Kidney transplant recipients (KTRs) experience increased risk of cardiovascular disease. Guidelines recommend HMG-CoA reductase inhibitor (statin) therapy when tolerated. We aimed to study changes in the prescription of statins and patients’ adherence to treatment over time. A population-based obser...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rønning, Marit, Hjellvik, Vidar, Sakshaug, Solveig, Blix, Hege Salvesen, Midtvedt, Karsten, Reisæter, Anna Varberg, Holdaas, Hallvard, Åsberg, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835204/ https://www.ncbi.nlm.nih.gov/pubmed/35162389 http://dx.doi.org/10.3390/ijerph19031370

Ejemplares similares

Urinary proteomic shotgun approach for identification of potential acute rejection biomarkers in renal transplant recipients
por: Loftheim, Håvard, et al.
Publicado: (2012)

Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient—No Intervention Actually Needed
por: Åsberg, Anders, et al.
Publicado: (2020)

Exposure to Mycophenolate and Fatherhood
por: Midtvedt, Karsten, et al.
Publicado: (2017)

A Comorbidity Index and Pretransplant Physical Status Predict Survival in Older Kidney Transplant Recipients: A National Prospective Study
por: Tsarpali, Vasiliki, et al.
Publicado: (2022)

Poor Physical Function Trajectory Predicts Impaired Patient Survival in Older Recipients of Deceased Donor Kidneys: A Prospective Cohort Study
por: Tsarpali, Vasiliki, et al.
Publicado: (2022)

Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors
por: Sverdrup Efjestad, Anne, et al.
Publicado: (2017)

Should patients older than 65 years be offered a second kidney transplant?
por: Heldal, Kristian, et al.
Publicado: (2017)

Improved Health-Related Quality of Life in Older Kidney Recipients 1 Year After Transplantation
por: Lønning, Kjersti, et al.
Publicado: (2018)

Body mass index, triglycerides, glucose, and blood pressure as predictors of type 2 diabetes in a middle-aged Norwegian cohort of men and women
por: Hjellvik, Vidar, et al.
Publicado: (2012)

Kidney Transplant Recipient Behavior During the Early COVID-19 Pandemic: A National Survey Study in Norway
por: Blom, Kjersti B., et al.
Publicado: (2021)

Drug Use before and after Initiating Treatment with Acetylcholinesterase Inhibitors
por: Efjestad, Anne Sverdrup, et al.
Publicado: (2019)

Sex differences in psychotropic and analgesic drug use before and after initiating treatment with acetylcholinesterase inhibitors
por: Efjestad, Anne Sverdrup, et al.
Publicado: (2021)

Use of Drugs With Risk of Heart Rate-Related Problems is Common in Norwegian Dementia Patients Treated With Acetylcholinesterase Inhibitors: A Prevalence Study Based on the Norwegian Prescription Database
por: Efjestad, Anne Sverdrup, et al.
Publicado: (2022)

Symmetric Dimethylarginine as Predictor of Graft loss and All-Cause Mortality in Renal Transplant Recipients
por: Pihlstrøm, Hege, et al.
Publicado: (2014)

Blood Pressure Treatment in Kidney Transplant Recipients—Can We Improve?
por: Onsøien, Mari O., et al.
Publicado: (2021)

One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts
por: Dörje, Christina, et al.
Publicado: (2015)

Paricalcitol supplementation during the first year after kidney transplantation does not affect calcification propensity score
por: Ussif, Amin, et al.
Publicado: (2018)

Humoral vaccine response and breakthrough infections in kidney transplant recipients during the COVID-19 pandemic: a nationwide cohort study
por: Hovd, Markus, et al.
Publicado: (2023)

Health-Related Quality of Life in Older Kidney Transplant Recipients: A National Cohort Study of Short- and Longer-Term Outcomes
por: Tsarpali, Vasiliki, et al.
Publicado: (2021)

Exploring the potential effect of paricalcitol on markers of inflammation in de novo renal transplant recipients
por: Pihlstrøm, Hege Kampen, et al.
Publicado: (2020)

The influence of CYP3A, PPARA, and POR genetic variants on the pharmacokinetics of tacrolimus and cyclosporine in renal transplant recipients
por: Lunde, Ingrid, et al.
Publicado: (2014)

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipients
por: Kared, Hassen, et al.
Publicado: (2023)

Increased risk of ischaemic heart disease after kidney donation
por: Haugen, Anders J, et al.
Publicado: (2021)

Mycophenolate pharmacokinetics and pharmacodynamics in belatacept treated renal allograft recipients – a pilot study
por: Bremer, Sara, et al.
Publicado: (2009)

An antibiotic’s journey from marketing authorization to use, Norway
por: Årdal, Christine, et al.
Publicado: (2017)

Kidney transplantation: an attractive and cost-effective alternative for older patients? A cost–utility study
por: Heldal, Kristian, et al.
Publicado: (2019)

Induction with interleukin-2 antagonist for transplantation of kidneys from older deceased donors: an observational study
por: Heldal, Kristian, et al.
Publicado: (2013)

Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management
por: Blom, Kjersti B., et al.
Publicado: (2023)

Incidence Trends of Atopic Dermatitis in Infancy and Early Childhood in a Nationwide Prescription Registry Study in Norway
por: Mohn, Cathrine H., et al.
Publicado: (2018)

Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients
por: Drevland, Ole Martin, et al.
Publicado: (2023)

Drug use differs by care level. A cross-sectional comparison between older people living at home or in a nursing home in Oslo, Norway
por: Fog, Amura Francesca, et al.
Publicado: (2019)

Regional differences in renal replacement therapy in northern Norway 2000–2012
por: Norum, Jan, et al.
Publicado: (2015)

Elevated Terminal C5b-9 Complement Complex 10 Weeks Post Kidney Transplantation Was Associated With Reduced Long-Term Patient and Kidney Graft Survival
por: Witczak, Bartlomiej J., et al.
Publicado: (2021)

Non-prescription purchase of antibiotics during travel abroad among a general adult population in Norway: Findings from the seventh Tromsø Study
por: Gravningen, Kirsten, et al.
Publicado: (2020)

Inflammation in the early phase after kidney transplantation is associated with increased long‐term all‐cause mortality
por: Heldal, Torbjørn Fossum, et al.
Publicado: (2022)

Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption – an individual-level prescription database study
por: Hartz, Ingeborg, et al.
Publicado: (2007)

Fasting Status and Circadian Variation Must be Considered When Performing AUC‐based Therapeutic Drug Monitoring of Tacrolimus in Renal Transplant Recipients
por: Gustavsen, Marte Theie, et al.
Publicado: (2020)

Are Octogenarians With End-Stage Renal Disease Candidates for Renal Transplantation?
por: Lønning, Kjersti, et al.
Publicado: (2016)

Predicting donor, recipient and graft survival in living donor kidney transplantation to inform pretransplant counselling: the donor and recipient linked iPREDICTLIVING tool – a retrospective study
por: Haller, Maria C., et al.
Publicado: (2020)

Antibiotic prescriptions and cycles of Mycoplasma pneumoniae infections in Norway: can a nationwide prescription register be used for surveillance?
por: BLIX, H. S., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1bvfph0psvh7s12l8t0umstugq